These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 37759)

  • 1. [Indoor treatment of involutional depressions in cerebro-vascular insufficiency (author's transl)].
    Hebenstreit G; Papadopulos P
    Aktuelle Gerontol; 1979 May; 9(5):223-30. PubMed ID: 37759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The systemic fibrinolytic effect of BRL 26921 during the treatment of acute peripheral arterial occlusions.
    Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
    Thromb Haemost; 1986 Apr; 55(2):259-62. PubMed ID: 3520938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of iliac artery stenosis with low dose streptokinase (author's transl)].
    Bopp J; Martin M; Büchner U; Auel H
    Dtsch Med Wochenschr; 1977 Feb; 102(6):198-201. PubMed ID: 137806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 5. [Late lysis therapy of chronic arterial occlusion. A new way to improve results (author's transl)].
    Müller-Fassbender H; Hess H
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1461-2. PubMed ID: 810668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial streptokinase in the treatment of acute arterial thrombosis.
    Seeger JM; Flynn TC; Quintessenza JA
    Surg Gynecol Obstet; 1987 Apr; 164(4):303-7. PubMed ID: 3563841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with Arwin (author's transl)].
    Hess H; Keil-Kuri E; Marshall M
    MMW Munch Med Wochenschr; 1975 Aug; 117(32-33):1317-20. PubMed ID: 819792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
    Traumann KJ
    Med Klin; 1976 Mar; 71(11):465-8. PubMed ID: 1263995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction.
    Squire IB; Lawley W; Fletcher S; Holme E; Hillis WS; Hewitt C; Woods KL
    Eur Heart J; 1999 Sep; 20(17):1245-52. PubMed ID: 10454976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and clinical aspects of thrombolysis.
    Verstraete M
    Semin Hematol; 1978 Jan; 15(1):35-54. PubMed ID: 341327
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of in situ arterial thrombolysis by the combination of urokinase and lysyl plasminogen in acute arterial occlusive diseases of the lower limbs].
    Pernes JM; Brenot P; Raynaud A; Parola JL; Roth JP; Angel CY; Vitoux JF; Fiessinger JN; Roncato M; Gaux JC
    J Radiol; 1985 May; 66(5):385-91. PubMed ID: 4032349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
    Kellner H
    MMW Munch Med Wochenschr; 1976 Oct; 118(43):1399-1402. PubMed ID: 825745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of urokinase during surgery: a new approach to the treatment of vascular obliterative disease (author's transl)].
    Fiessinger JN; Vayssairat M; Juillet Y; Janneau D; Aiach M; Cormier JM; Housset E
    Ann Med Interne (Paris); 1979; 130(4):215-8. PubMed ID: 475207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of streptokinase therapy in arterial obliterative diseases].
    Zola-Sleczek E; Skawiński S; Targosz-Naturska H; Szczeklik J
    Kardiol Pol; 1973; 16(4):309-16. PubMed ID: 4756965
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential treatment of arterial occlusions with porcine plasmin and low dose streptokinase.
    Marbet GA; Eichlisberger R; Duckert F; da Silva MA; Biland L; Widmer LK; Ritz R; Schmitt HE
    Thromb Haemost; 1982 Oct; 48(2):187-9. PubMed ID: 6217580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Streptokinase in arterial diseases].
    Baracchi G
    Minerva Med; 1979 Jan; 70(2):143-7. PubMed ID: 155227
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
    Kharash LM; Goldkhammer EI
    Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.